Ablynx Nv Ads





Please Login or Register

Login|Register FREE

Stock Price
Open: 54.00
Prev. Close: 54.04
Low/Hi: 53.91 - 54.05
52-Week: 17.75 - 54.87
Equity: 12,975
90-Day Avg: 337,794
Option: 2
90-Day Avg: 700
Todays Stock Vol: 3.1
20-Day (HV): 9.8
52-Week (HV): 34.1
30-Day IV: 18.6 +0.8
IV Pct Rank: 12% Subdued
Div. Yield:
Earnings: 17-May
P/E Ratio:
Market Cap: 4.1 B
Short Int Pct: 0.0%
Pct Held By Inst.: 17.7%
Stock Info
Type: Common
Sector: N/A
Industry: N/A

About ABLX

Ablynx is a Belgian biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments. The Company has approximately 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)

ABLX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
MRGR ProShares Merger ETF 4.4 M 4445040 43 43 3.43% 0.0343126 115 K 115090

Wait, Before You Leave...

Want to Know More About ABLX Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon